Introduction
The Enterococcus feacium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter sp. (ESKAPE) pathogens frequently acquire drug resistance. Nosocomial infections from multidrugresistant (MDR) pathogens often have poor outcomes, especially in intensive care units. A. baumannii is a Gram-negative pathogen of opportunistic infection, and MDR A. baumannii (MDRA) strains are often resistant to major antibiotics such as amikacin (AMK), ciprofloxacin (CIP), and imipenem (IPM). 1, 2 A fatal MDRA outbreak occurred in 2010 at Teikyo University Hospital (Tokyo, Japan). 3, 4 In this study, we compared the pathogenicity of A. baumannii clinical isolates including MDRA strains. Despite many clinical studies, little is known regarding the virulence and microbial fitness of A. baumannii. The greater wax moth Galleria mellonella may be useful for the prospective evaluation of microbial pathogens in randomized controlled studies 5 as infectivity and antibiotic responses show strong concordance with mammalian infection models, 6 particularly for A. baumannii. 5, 7 Furthermore, this in vivo system has obvious ethical and logistical advantages over mammalian infection models. The objectives of this study were to assess the virulence and antibiotic response profiles of carbapenem-resistant A. baumannii (CRAB) isolates from this fatal outbreak using the G. mellonella host model.
Materials and methods ethics
The Teikyo University Animal Ethics Committee exempted this study.
Materials
Ampicillin (AMP) and kanamycin (KAN) were purchased from Meiji Seika Pharma (Tokyo, Japan). Cefepime (FEP) was purchased from Bristol-Myers Squibb (New York, NY, USA). Colistin (CST), minocycline (MIN), polymyxin B (PMB), and tetracycline (TET) were purchased from SigmaAldrich Co. (St Louis, MO, USA). AMK and tigecycline (TGC) were purchased from Wako Pure Chemical Industries (Osaka, Japan). Sitafloxacin (STX) was purchased from Cimic CMO (Tokyo, Japan). Cefozopran (ZOP), doxycycline (DOX), and IPM were generously provided by Takeda Pharmaceutical (Osaka, Japan), Pfizer (New York, NY, USA), and Banyu Pharmaceutical (Tokyo, Japan), respectively. CIP, sparfloxacin (SPX), and meropenem (MEM) were generously provided by Sumitomo Dainippon Pharma (Osaka, Japan 
Isolation and characterization of A. baumannii
A. baumannii clinical isolates were previously collected from Teikyo University Hospital, a 1,082-bed academic hospital in Tokyo, Japan, 4 and stored in glycerol at -80°C. During the MDRA outbreak from 2009 to 2010, 59 patients were infected and nine patients who had hematological diseases died as a result of the infection. A. baumannii strains were originally isolated from blood, sputum, stool, urine, bronchoalveolar lavage, pus, and pharyngeal mucus specimens. All clinical isolates of A. baumannii were identified at the species level by the rpoB sequence. 8 Carbapenem resistance was confirmed by the broth microdilution method. Antibiotic susceptibility was interpreted according to Clinical and Laboratory Standards Institute (CLSI) guidelines (document M100-S22). Each isolate exhibited a unique pattern on pulse-field gel electrophoresis (PFGE) (Kawakami, in preparation, 2018). Frozen stocks of A. baumannii were streaked on LB agar and incubated at 37°C. A. baumannii isolates were grown at 37°C in LB for liquid culture in Bioshaker BR-40LF (Taitec, Tokyo, Japan).
Gene amplification and DNA sequencing
A genomic fragment was amplified by PCR using KOD FX Neo (Toyobo, Osaka, Japan). RNA polymerase β-subunit gene rpoB was amplif ied according to a previously described protocol. 8 DNA sequences were determined by direct sequencing using a BigDye Terminator v3.1 Cycle Sequencing Kit and ABI PRISM 3100 Genetic Analyzer (Thermo Fisher Scientific, Waltham, MA, USA). Sequences were compared using NCBI BLASTN 2.7.1. Presence of the bla OXA-51 -like gene was confirmed by PCR with primers OXA-51A (5′-CTAATAATTGATCTACTCAAG-3′) and OXA-51B (5′-CCAGTGGATGGATGGATAGATTATC-3′), while presence of the armA gene was determined using primes armA-F (5′-AGGTTGTTTCCATTTCTGAG-3′) and armA-R (5′-ATCTCTTCCATTCCCTTCTCC-3′). 9, 10 antimicrobial activity 
Infection model
G. mellonella larvae (250-350 mg) were purchased from Live Bait Factory (Osaka, Japan). Each isolate was diluted in saline (0.9% NaCl) and 10 µL was injected into the rear right proleg of 10 randomly selected G. mellonella larvae using an insulin syringe (Terumo, Tokyo, Japan). Saline (0.9% NaCl) and injection-free groups (both n=10) were used to evaluate the effects of trauma and attrition, respectively. G. mellonella larvae were incubated at 37°C. Death was defined as unresponsiveness to touch. 7 Survival curves were plotted using Kaleidagraph 4.1.4 (Synergy Software, Reading, PA, USA), and median lethal dose (LD 50 ) values were determined by curve fitting at 24h.
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For evaluating antibacterial activity against MDRA, 10 µL of antimicrobial agents were injected into the rear left proleg of 10 G. mellonella larva infected with MDRA TK1033. Saline was used as a control of agents. Antimicrobial doses were 40 mg/kg each.
statistical analysis
Statistical analysis was performed using Microsoft Excel 2007 for Windows (Redmond, WA, USA) and Excel Statistics 2008 (Social Survey Research Information, Tokyo, Japan). Survival plots were generated by the Kaplan-Meier method and compared among antibiotics by the log-rank test. Differences between log CFU values were tested for significance by one-way ANOVA followed by Fisher's least significant difference tests for pair-wise comparisons. A P-value of <0.05 was considered to be statistically significant. All tests were two-tailed.
Results

Pathogenicity of A. baumannii clinical isolates in G. mellonella
Sixteen unique pulse-field gel electrophoresis (PFGE) isolates were tested in the G. mellonella infection model. Colonyforming units were used to confirm the injected inocula. Injection of A. baumannii isolates resulted in time-dependent and dose-dependent larval death, but LD 50 values varied markedly (Table 1) . We then compared the LD 50 values among drug-sensitive, MEM/CIP-resistant, CIP/AMK-resistant, and MEM/CIP/AMK-resistant (MDRA) isolates (Figure 1) Next, we compared the survival of G. mellonella infected with AMK-sensitive and -resistant isolates. At 24 h postinoculation, the LD 50 values of the 13 AMK-resistant isolates were lower than those of the four AMK-sensitive isolates ( Figure  2A) . Furthermore, G. mellonella larvae were killed more rapidly by the 13 AMK-resistant isolates than the four AMKsensitive isolates (P=2.5×10 −7 ). For instance, after 2 days, 62% of the G. mellonella larvae inoculated with AMK-sensitive isolates survived, compared to only 20% inoculated with AMK-resistant isolates (Figure 2A) . The presence of the armA gene coding 16S rRNA methyltransferase was confirmed in all AMK-resistant isolates by PCR, suggesting that armA-positive isolates are generally more virulent against G. mellonella larvae than armA-negative isolates (except for the AMK-sensitive, KAN-resistant and armA-positive isolate TK1024).
CRAB isolates also induced greater mortality of G. mellonella than carbapenem-sensitive A. baumannii (CSAB) isolates (P=0.011, Figure 2B ). The isolates with intermediate carbapenem resistance showed virulence comparable to CRAB (P=0.47) and CSAB (P=0.13). In our study, G. mellonella lar- 
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Cefozopran for multidrug-resistant A. baumannii vae were killed more rapidly by bla OXA-23 -negative isolates of A. baumannii than bla OXA-23 -positive isolate TK1032 (Table 1) . These results suggest that clinical isolates harboring the bla OXA-23 gene and those involved in an outbreak may be less virulent.
antibiotic sensitivity of highly virulent MDRa
Next, we evaluated the antibiotic sensitivity of the MDRA isolate TK1033 (Table 2 ). TK1033 was resistant to aminoglycosides such as KAN and AMK. TK1033 was also resistant to the TET antibiotics TET and DOX but sensitive to the TET antibiotics MIN and TGC. Similarly, TK1033 was sensitive to the fourth-generation quinolone antibiotic STX but resistant to the second-generation quinolone CIP and the third-generation quinolone SPX. TK1033 was also sensitive to the polymyxins PMB and CST. TK1033 was resistant to the fourth-generation cephalosporin FEP but sensitive to another fourth-generation cephalosporin, ZOP.
antibacterial treatment of MDRa with the fourth-generation cephalosporin ZOP
It has previously been shown that appropriate antimicrobials can successfully treat G. mellonella infected with A. baumannii. 7 To determine whether the G. mellonella-MDRA infection model can be used to study the in vivo activity of antibacterial agents against our clinical isolates, we investigated the effects of single-dose (40 mg/kg) ZOP, CST, PMB, MIN, TGC, and STX on MDRA-infected G. mellonella larvae (Figure 3) . Initially, we infected G. mellonella larvae with the MDRA strain TK1033. Treatment with antibiotics that had in vitro activity against this A. baumannii strain significantly prolonged the survival of G. mellonella larvae. Thus, the G. mellonella-MDRA infection model can be used as an alternative to mammalian systems for the assessment of antibacterial agent efficacy.
Discussion
The pathogenicity of A. baumannii clinical strains has been studied using G. mellonella. The US military clinical isolate AB5075 exhibited a 100-fold lower LD 50 in the G. mellonella infection model than strain American Type Culture Collection (ATCC) 19606. 12 Another clinical strain, ATCC 17978, exhibited a twofold lower LD 50 than ATCC 19606. In contrast, the epidemiological outbreak strains AYE and ACICU presented about twofold higher LD 50 values than ATCC 17978. 13 Therefore, A. baumannii strains show a broad range of virulence values and resistance profiles in vitro that do not always correspond with clinical outcome. Thus, the clinical relevance of different strain characteristics in epidemiological outbreaks is uncertain. In this study, we selected clinical isolates previously classified at our institution to analyze the relevance of individual resistance spectra to clinical virulence. MDR (MEM/CIP/AMK) isolates of A. baumannii appeared to be more virulent than double-resistant (MEM/CIP and CIP/AMK) isolates (Figure 1 ). In particular, TK1033 exhibited a 500-fold lower LD 50 in the G. mellonella infection model than strain ATCC 19606 (Table 1) . Isolates with the same PFGE pattern as the highly virulent strain TK1033 were most frequently isolated during the outbreak, suggesting clinically significant infectivity and pathogenicity to humans. However, extrapolation of these results to human virulence will require additional study using a mouse infection model. Our previous report has suggested that the lipopolysaccharide (LPS) subtype of the outbreak strain is also a possible virulence factor. Indeed, the LPS from TK1033 induced greater expression of proinflammatory cytokine genes in human polymorphonuclear leukocytes than that from a drug-sensitive A. baumannii in vitro.
14 Some studies have reported hypervirulent strains in epidemic outbreak isolates and have analyzed the pathogenicity in animal infection models. 12, [15] [16] [17] The horizontal clonal spread of hypervirulent strains may contribute to epidemic outbreaks and poor clinical outcomes. Further study is warranted to elucidate virulence in animal models and clinical outcomes.
Recently, Lemos et al (2014) 18 conducted a systematic review and meta-analysis of carbapenem resistance and mortality in patients with A. baumannii infection. CRABinfected patients showed significantly higher mortality risk than CSAB-infected patients, although there was a substantial 19 Therefore, differences in virulence among CRAB clones may partly contribute to the heterogeneous results in clinical studies. The results of the present study appear consistent with those of previous clinical studies, suggesting that carriage of carbapenem-resistance genes is associated with organism virulence, although with some variance ( Figure 2B ). While these studies demonstrated increased mortality among patients with CRAB vs CSAB bloodstream infections on bivariate inspection, this does not exclude the possibility that patient comorbidities drive poor outcomes or that patients with more comorbidities are more likely to be infected by CRAB.
In our study, G. mellonella larvae were killed more rapidly by bla OXA-23 -negative isolates of A. baumannii than bla OXA-
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-positive isolate of A. baumannii. These results suggest that clinical isolates harboring the bla OXA-23 gene and those involved in an outbreak may be less virulent, consistent with a previous study regarding clinical isolates harboring the bla OXA-40 gene and those involved in an outbreak. 5 However, another study reported a highly virulent isolate, AB5075, harboring bla OXA-23 and involved in an outbreak. 12 Hence, the impact of carbapenem resistance on mortality due to A. baumannii infection remains uncertain.
In contrast to bla OXA-23 -positive isolate, AMK-resistant isolates of A. baumannii killed G. mellonella larvae more rapidly than AMK-sensitive isolates (Figure 2A ). These results suggest that clinical isolates harboring the armA gene coding 16S rRNA methyltransferase and those involved in an outbreak may be more virulent. The impact of AMK resistance and/or the armA gene on mortality due to A. baumannii infection warrants further study in light of this possibility.
In this study, we utilized G. mellonella to compare the pathogenicity of A. baumannii clinical isolates and to assess the efficacy of antibiotic treatment against a highly pathogenic MDRA. Very little is known about the pathogenicity of MDRA, so this infection model may serve as a useful tool for future research. Interestingly, we observed an association between the pathogenicity of MDRA in G. mellonella and that observed in humans. Therefore, this model may also facilitate the study of novel compounds against MDRA with the ethical and logistical advantages over mammalian models. Mammalian infection models should be used to confirm our results before human studies in the future.
The third-generation cephalosporins are widely used for the empiric therapy of serious nosocomial infections. However, expression of β-lactamase (eg, AmpC) may confer resistance. Fourth-generation cephalosporins have potent activity against Gram-negative bacteria including those producing AmpC β-lactamase. 20, 21 ZOP is a fourth-generation cephalosporin approved for various bacterial infections in Japan. 22 The highly virulent MDRA TK1033 isolate was more sensitive to ZOP than FEP (Table 2) . TK1033 was also sensitive to MIN and TGC, both of which are used for empiric therapy of MDRA infection. [23] [24] [25] [26] [27] Intravenous MIN is particularly promising due to its improved safety profile. [25] [26] [27] ZOP and/or MIN were used for empiric therapy during the MDRA outbreak in our hospital. Antibacterial activities of ZOP and MIN in vitro and in vivo were confirmed in this study (Table 2 and Figure 3) . Re-evaluation and use of fourthgeneration cephalosporins and MIN may help reduce the use of carbapenems, resulting in reduced carbapenem-resistance for antimicrobial stewardship.
